Acrivon Therapeutics (NASDAQ:ACRV) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a sell rating to a hold rating in a research note published on Saturday morning,Wall Street Zen reports. Separately, Weiss Ratings upgraded shares of Acrivon Therapeutics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, […]
20 Sep 06:12 · The Markets Daily